MedPath

湖北济得药业有限公司

Ownership
-
Established
2020-06-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Dextran 40 and Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H20053310
Approval Date
Aug 10, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20083885
Approval Date
Aug 10, 2020
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20043461
Approval Date
Aug 10, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20023297
Approval Date
Aug 10, 2020
NMPA

Levofloxacin Lactate and Sodium Chloride Injection

Product Name
乳酸左氧氟沙星氯化钠注射液
Approval Number
国药准字H20055528
Approval Date
Aug 10, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20043302
Approval Date
Aug 10, 2020
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H20093653
Approval Date
Aug 10, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20023298
Approval Date
Aug 10, 2020
NMPA

Fleroxacin and Glucose Injection

Product Name
氟罗沙星葡萄糖注射液
Approval Number
国药准字H20057960
Approval Date
Aug 10, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20043397
Approval Date
Aug 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.